Upendarrao Golla

13PUBLICATIONS
31CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 09, 2026
CK2 inhibitor, CX-4945, enhances BH3 priming and promotes apoptosis of venetoclax-resistant AML by targeting antiapoptotic proteins.

Muhammad Daniyal, Rajesh Rajaiah, Upendarrao Golla

|Oct 26, 2024
From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies.

Upendarrao Golla, Satyam Patel, Nyah Shah

|Apr 27, 2024
Role of Immune Cells and Immunotherapy in Multiple Myeloma.

Vijay Radhakrishnan, Upendarrao Golla, Avinash Kundadka Kudva

|Mar 28, 2024
Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression.

Scott Auerbach, Beana Puka, Upendarrao Golla

|Aug 26, 2023
Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases.

Vijay Pralhad Kale, Jeremy A Hengst, Arati K Sharma

Pageof 3